Position in MNKD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$590,457
+$250,875 QoQ
Shares Held
138,605
0.0% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 254 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KING LUTHER CAPITAL MANAGEMENT CORP holds $11,681,102 across 6 Biotechnology names. MNKD ranks #4 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
67,333 | $5,270,153 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
53,725 | $4,379,124 | |
| 3 | ABSI |
Absci Corp
|
77,520 | $898,456 | |
| 4 | MNKD |
Mannkind Corp
This page
|
138,605 | $590,457 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
800 | $498,832 | |
| 6 | RANI |
Rani Therapeutics Holdings, Inc.
|
58,000 | $44,080 |
All Filings in MNKD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $590,457 | 138,605 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $339,582 | 138,605 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $583,981 | 102,995 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||